Premature release of clinical trials data

From The Embassy of Good Science
Cases

Premature release of clinical trials data

What is this about?

This blog post describes a controversy that involved an industrial partner eager to report the results of an ongoing clinical trial based on analysing the first 25% of data.

Why is this important?

It shows that academic and industrial research partners might have different priorities that do not always match.

For whom is this important?

Other information

Cookies help us deliver our services. By using our services, you agree to our use of cookies.
5.1.6